Author Details

Maĭkov, E B, ФГБУ "Российский кардиологический научно-производственный комплекс" Минздрава России, Москва, Россия

Issue Section Title File
Vol 87, No 1 (2015) Editorial Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies